456 related articles for article (PubMed ID: 26012567)
1. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
[TBL] [Abstract][Full Text] [Related]
2. TWEAKing for a fight with GVHD.
MacEwan DJ
Blood; 2015 Jul; 126(4):429-30. PubMed ID: 26206942
[TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
[TBL] [Abstract][Full Text] [Related]
4. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
[TBL] [Abstract][Full Text] [Related]
7. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
Echeverry R; Wu F; Haile WB; Wu J; Yepes M
J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
[TBL] [Abstract][Full Text] [Related]
8. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
[TBL] [Abstract][Full Text] [Related]
9. Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity.
Zaitseva O; Hoffmann A; Löst M; Anany MA; Zhang T; Kucka K; Wiegering A; Otto C; Wajant H
Front Immunol; 2023; 14():1194610. PubMed ID: 37545514
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
[TBL] [Abstract][Full Text] [Related]
11. TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice.
Son A; Oshio T; Kawamura YI; Hagiwara T; Yamazaki M; Inagaki-Ohara K; Okada T; Wu P; Iseki M; Takaki S; Burkly LC; Dohi T
Mucosal Immunol; 2013 Nov; 6(6):1131-42. PubMed ID: 23462911
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-like weak inducer of apoptosis or Fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice.
Tarín C; Fernández-Laso V; Sastre C; Madrigal-Matute J; Gómez M; Zaragoza C; Egido J; Burkly LC; Martín-Ventura JL; Blanco-Colio LM
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092786
[TBL] [Abstract][Full Text] [Related]
14. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
15. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
16. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
[TBL] [Abstract][Full Text] [Related]
17. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.
Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH
J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560
[TBL] [Abstract][Full Text] [Related]
18. Development of an Fn14 agonistic antibody as an anti-tumor agent.
Michaelson JS; Amatucci A; Kelly R; Su L; Garber E; Day ES; Berquist L; Cho S; Li Y; Parr M; Wille L; Schneider P; Wortham K; Burkly LC; Hsu YM; Joseph IB
MAbs; 2011; 3(4):362-75. PubMed ID: 21697654
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.
Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C
Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296
[TBL] [Abstract][Full Text] [Related]
20. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade.
van Kuijk AW; Wijbrandts CA; Vinkenoog M; Zheng TS; Reedquist KA; Tak PP
Ann Rheum Dis; 2010 Jan; 69(1):301-4. PubMed ID: 19147618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
